Curtis Gale Oltmans, General Counsel at ARRAY BIOPHARMA INC (ARRY), sold 40,000 shares at $20.00 ($800K) on 2019-02-05, disclosed to the SEC on 2019-02-07.
Open-market sale of $800k ARRY by General Counsel. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ARRY | SELL | 2019-01-29 | $253K | — | Filing → |
| ARRY | SELL | 2019-01-23 | $23K | — | Filing → |
| ARRY | SELL | 2019-01-17 | $712K | — | Filing → |